Focus:
On 6 October, Flexion Therapeutics announced the approval of Zilretta for the treatment of pain associated with moderate-to-severe knee osteoarthritis.
The healthcare sector is rapidly going through a transition phase, with Internet of Medical Things devices revolutionising health IT infrastructure such as electronic health records (EHR) and big data analytics...
Osteoarthritis (OA) is one the developed world’s most common diseases, with over 80% of the senior population suffering from knee or hip OA.
The past 15 years have witnessed an explosion in the drugs market for multiple sclerosis (MS), enabling the first disease modifying therapies in the neurodegenerative disease market to become a...
Artificial intelligence (AI) is being implemented in almost every aspect of day-to-day life. From recommendations on Netflix or Spotify and fraud detection for your bank account, to experimental self-driving cars,...
This month, Merck’s Mavenclad (cladribine) become available in the UK to treat highly active relapsing multiple sclerosis (MS). Mavenclad is the first high efficacy, infrequent dosing oral agent approved for...
Once hailed as the next great thing in female sterilization, Bayer’s Essure device will no longer be sold outside of the US, the company announced on Monday.
While covering an expansive number of cardiovascular (CV) indications, this year’s European Society of Cardiology (ESC) Conference in Barcelona had a particular focus on digital health.
Following a move to fix price ceilings for coronary stent products, India’s National Pharmaceutical Pricing Authority (NPPA) has announced a plan to cap the pricing of orthopedic knee replacement implants.
In July 2017, Pentax Medical and Shanghai AoHua Photoelectricity formed a joint venture (JV) company to develop products in the field of flexible medical endoscopy.
